DUBLIN – Immunoqure AG is parlaying an extensive auto-antibody characterization effort involving a cohort of patients with an ultra-rare autoimmune disease into an antibody discovery engine that has uncovered large numbers of highly active antibodies with the potential to address a swath of immunological conditions.